Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Bruker (BRKR) over the last 16 years, with Q3 2025 value amounting to $4.1 billion.

  • Bruker's Non-Current Assets rose 415.15% to $4.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 billion, marking a year-over-year increase of 3531.83%. This contributed to the annual value of $814.8 million for FY2024, which is 1784.78% up from last year.
  • As of Q3 2025, Bruker's Non-Current Assets stood at $4.1 billion, which was up 415.15% from $4.2 billion recorded in Q2 2025.
  • Over the past 5 years, Bruker's Non-Current Assets peaked at $4.2 billion during Q2 2025, and registered a low of $466.0 million during Q4 2021.
  • Its 5-year average for Non-Current Assets is $1.9 billion, with a median of $1.3 billion in 2022.
  • Its Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 64.79% in 2021, then skyrocketed by 12403.06% in 2024.
  • Quarter analysis of 5 years shows Bruker's Non-Current Assets stood at $466.0 million in 2021, then rose by 15.49% to $538.2 million in 2022, then rose by 28.47% to $691.4 million in 2023, then grew by 17.85% to $814.8 million in 2024, then skyrocketed by 401.26% to $4.1 billion in 2025.
  • Its last three reported values are $4.1 billion in Q3 2025, $4.2 billion for Q2 2025, and $3.8 billion during Q1 2025.